Sort
82,697 grants matching “vaccine development”
Role of Follicular T Helper Cells In Enhancing Humoral Immunity and Protection
$721,267Rafi Ahmed · Emory University · U19 · FY2011 · AI
Mechanisms of MERS-CoV Entry, Cross-species Transmission and Pathogenesis
$721,207Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Personalized vaccine for patients with AML
$721,179David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Personalized vaccine for patients with AML
$721,179David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Chikungunya Virus Replication and Pathogenesis
$721,175Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Novel Adenovirus Vaccine Vectors for HIV/SIV
$721,067Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2010 · AI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
$721,045Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2024 · AI
Control of Tsetse Fly Transmitted Diseases in Kenya
$720,837Serap Aksoy · Yale University · U01 · FY2016 · AI
Structure-Based Design of a Broadly Protective Group A Streptococcal Vaccine
$720,717James B. Dale · University Of Tennessee Health Sci Ctr · R01 · FY2017 · AI
HIV and Hepatitis C Pathogenesis & The Human Genome
$720,712David L Thomas · Johns Hopkins University · R01 · FY2017 · DA
HIV and Hepatitis C Pathogenesis & The Human Genome
$720,712David L Thomas · Johns Hopkins University · R01 · FY2018 · DA
Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice
$720,697Jeremy Allen Goettel · Vanderbilt University Medical Center · R01 · FY2023 · AI
Mechanisms and Population Genomics of Pneumococcal Antigenic Diversity
$720,696Marc Lipsitch · Harvard School Of Public Health · R01 · FY2013 · AI
Drug target validation of the enterovirus D68 2A protease
$720,664Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
CD4 T cell control of cytomegalovirus
$720,659Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2019 · AI
CD4 T cell control of cytomegalovirus
$720,659Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2020 · AI
Motivational Interviewing Training to Promote COVID-19 and Influenza Vaccination (MI-VAX): What Providers Need and Patients Want
$720,657Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · MD
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$720,632Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment
$720,613Christopher D Vanderwal · University Of California-Irvine · R01 · FY2019 · AI
Development of Broadly Protective Vaccines against New World Arenaviruses
$720,588Yuying Liang · University Of Minnesota · R01 · FY2025 · AI
Development of RhCMV Vectors for SIV Infection
$720,581Louis J. Picker · Oregon Health & Science University · R01 · FY2007 · AI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi
$720,419Linden T Hu · Tufts University Boston · R01 · FY2021 · AI
Chemoenzymatic synthesis of bacterial polysaccharides
$720,360Hai Yu · University Of California At Davis · U01 · FY2020 · GM
Statistical Issues in AIDS Research
$720,355James P Hughes · University Of Washington · R37 · FY2022 · AI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$720,328Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA